Treatment of Pre cancer condition affecting the cervix of Uterus with Bhandira churna

Effect of Bhandira Churna (Clerodendrum viscosum) in Garbhashaya Mukha Vrana Sopha w.s.r to Low Grade Squamous Intraepithelial lesion (LSIL)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/12/047883

Enrollment

142

Registered

2022-12-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Females with clinical signs & symptoms like white discharge p/v, lower abdominal pain, low back ache, dyspareunia, contact bleeding, hypertrophy of cervix, cervical erosion, cervicitis and diagnosed with cervical cell pathology of Low grade Squamous Intraepithelial Lesion/ ASCUS /Koilocytic atypia/ CIN I as per The Bethesda System Terminology

Exclusion criteria

Exclusion criteria: 1.Females diagnosed with HSIL/ CIN II/ CIN III/ Carcinoma in situ (CIS) 2.Diagnosed cases of CA cervix 3.Females diagnosed with TB, STD & HIV 4.Pregnant and lactating females

Design outcomes

Primary

Measure	Time frame
20 percentage Regression in VIA Pap smear and Colposcopy findings Comparative efficacy of group A & B Timepoint: 4 months	—

Secondary

Measure	Time frame
Change in signs and symptoms discharge per vaginum vulval itching Burning micturition dyspareunia burning micturition lower abdominal pain low back ache and cervical erosionTimepoint: 4 months	—

Countries

India

Contacts

Public ContactDr Kamini Dhiman

All India Institute of Ayurveda

drkaminidhiman@outlook.com8920900968

Outcome results